Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1994-09-22
1997-10-21
Walsh, Stephen
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 697, 4352402, 4352523, 4353201, 530350, 530412, 536 234, C12N 1562, C07K 14705
Patent
active
056795467
ABSTRACT:
The present invention relates to novel chimeric proteins comprising a first polypeptide which inhibits complement activation, linked to a second polypeptide which inhibits complement activation, nucleic acids encoding novel chimeric proteins and methods of reducing inflammation with the administration of the chimeric proteins of the invention.
REFERENCES:
patent: 4774180 (1988-09-01), Toth et al.
patent: 5252216 (1993-10-01), Folena-Wasserman et al.
patent: 5264357 (1993-11-01), Caras et al.
Lublin et al., "Decay-Accelerating Factor: Biochemistry, Molecular Biology, and Function", Ann. Rev. Immunol., 7:35-58 (1989).
Miyagawa et al., "Effect of Transfectant Molecules, MCP, DAF, and MCP/DAF Hybrid, on Complement Mediated Swine Endothelial Cell Lysis", Molec. Immunol., Abstracts of the XV International Complement Workshop, Kyoto, Japan, 30:(Supp 1), (Sep., 1993).
Lee, et al., "Cloning with Tandem Genes Systems for High Level Gene Expression", 1984, Nucleic Acids Res. 12(17):6797-811.
Telen et al., "Molecular Mapping of the Cromer Blood Group Cr.sup.a and Tc.sup.a Epitopes of Decay Accelerating Factor: Toward the Use of Recombinant Antigens in Immunohematology", Blood, 84(9):3205-11.
Pichler, R., et al., "Tubulointerstitial Disease in Glomerulonephritis: Potential Role of Osteopontin (Uropontin)", 1994, Am. J. Pathology, 144(5):915-23.
Vakeva, A., et al., "Animal Model: Time Course of Complement Activation and Inhibitor Expression after Ischemic Injury of Rat Myocardium", 1994, Am. J. Pathology, 144(6):1357-68.
Adams, E.M., et al., "Contribution of the Repeating Domains of Membrane Cofactor Protein (CD46) of the Complement System to Ligand Binding and Cofactor Activity", 1991, J. Immunol., 147:3005-3011.
Bailey, P.J., et al., "Immune Complexes and Inflammation: A Study of the Activity of Anti-Inflammatory Drugs In The Reverse Passive Arthus Reaction in the Rat", 1983, Biochem. Pharmacol., 32:475-81.
Caldwell, F.T., et al., "Relationships Between Heat Production, Heat Loss, and Body Temperature for Rats With Burn Injuries Between 26% and 63% of the Body Surface Area", 1993, J. Burn Care & Rehab., 14:420-26.
Coyne, K.E., et al., "Mapping of Epitopes, Glycosylation Sites, and Complement Regulatory Domains in Human Decay Accelerating Factor", 1992, J. Immunol., 149:2906-13.
Hosea, S., et al., "Role of Complement Activation in a Model of Adult Respiratory Distress Syndrome", 1980, J. Clin. Invest., 66:375-82.
Hussey, R.E., et al., "A Soluble CD4 Protein Selectively Inhibits HIV Replication and Syncytium Formation", 1988, Nature, 331:78-81.
Iwata, K., et al., "Expression of a Hybrid Complement Regulatory Protein, Membrane Cofactor Protein Decay Accelerating Factor on Chinese Hamster Ovary", 1994, J. Immunol., 152:3436-3444 (Apr. 1, 1994).
Krych, M., et al., "Analysis of the Functional Domains of Complement Receptor Type 1 (C3b-C4b Receptor; CD35) by Substitution Mutagenesis", 1994, J. Biol. Chem., 269:13273-278.
Leventhal, J.R., et al., "Prolongation of Cardiac Xenograft Survival by Depletion of Complement", 1993, Transplantation, 55:857-66.
Linington, C., et al., "The Role of Complement in the Pathogenesis of Experimental Allergic Encephalomyelitis", 1989, Brain, 112:895-911.
Steer, M.L., "Pathobiology of Experimental Acute Pancreatitis", 1992, Yale J. Biol. and Med., 65:421-30.
Weisman, H.F., et al., "Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardian Inflammation and Necrosis", 1990, Science, 249:146-51.
Molina et al, "Analysis of Epstein-Barr Virus-binding Sites on Complement Receptor 2 . . .", J. Biol. Chem. 266(19): 12173-12179 (Jul. 1991).
Kalli et al, "Mapping of the C3b-Binding Site of CR1 and Construction of a (CR1).sub.2 -F(ab').sub.2 Chimeric . . . ", J. Exp. Med. 174:1451-1460 (Dec. 1991).
Ko Jone-Long
Yeh C. Grace
Brown Karen E.
CytoMed, Inc.
Walsh Stephen
LandOfFree
Chimeric proteins which block complement activation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric proteins which block complement activation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric proteins which block complement activation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1006034